Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11951098 Therapeutic agent for meibomian dysfunction
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
February 16, 2023
0
Date of Patent
April 9, 2024
0
Patent Application Number
18170246
0
Patent Citations
US Patent 7001607 Artificial tear replacement solution
0
US Patent 7083802 Treatment of ocular disease
0
US Patent 8298569 Ophthalmic emulsions containing an immunosuppressive agent
0
US Patent 8313763 Sustained delivery formulations of rapamycin compounds
0
US Patent 8367081 Macrocyclic lactone compounds and methods for their use
0
US Patent 8404641 Macrocyclic lactone compounds and methods for their use
0
US Patent 8541413 Sustained release eye drop formulations
0
US Patent 8614178 Pharmaceutical composition for treatment of dry eye syndrome
0
US Patent 8765725 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
0
US Patent 9278120 Inflammatory eye disorders
0
•••
Patent Inventor Names
Daisuke Shii
0
Hideki Miyake
0
Tomoko Oda
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11951098
0
Patent Primary Examiner
Dominic Lazaro
0
Find more entities like US Patent 11951098 Therapeutic agent for meibomian dysfunction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE